Bedtime dosing of blood pressure drugs reduces diabetes risk
by Bruce Sylvester: Blood pressure drug dosing at bedtime instead of in the morning not only lowers blood pressure during sleep but significantly reduces the risk of type… read more.
by Bruce Sylvester: Blood pressure drug dosing at bedtime instead of in the morning not only lowers blood pressure during sleep but significantly reduces the risk of type… read more.
Graham Jackson, Professor of Clinical haematology, Newcastle upon Tyne and former president of the British Society for Haematology (BSH). Article by Christine Clark: In the 1970s the prospect… read more.
by Bruce Sylvester: Atrial fibrillation patients treated with digoxin have a 27 percent greater risk of dying than atrial fibrillation patients not treated with the drug, according to… read more.
by Bruce Sylvester: In the non-cardiac surgical setting, neither aspirin nor clonidine taken perioperatively appears to reduce the risk of acute kidney injury, researchers reported on Nov. 15,… read more.
Despite global improvements in life expectancy, death rates for some causes — including drug use and liver cancer — continue to rise. Global life expectancy increased by 5.8… read more.
World Health Matters – Australia- by Gary Finnegan: New research suggests treatment in Australia and New Zealand for patients with sepsis is the best in the world but… read more.
by Bruce Sylvester – Microvascular complications of diabetes that can lead to blindness and amputations might be reduced by statin therapy, researchers reported on Sept.9, 2014 in The Lancet… read more.
Ger Walpole, CNS (Clinical Nurse Specialist), H.Dip Oncology Nursing, BNS(Hons), Sligo Regional Hospital, Sligo. Dr Andrew Hodgson, MB, BS, BSc (Hons), FRCPI, FFPath, FRCPath. Written by Karen Mas-Mollinedo… read more.
by Thomas R. Collins – After evaluating data on 5 million adults in the UK, researchers concluded that an increasing body mass index (BMI) raises the odds of… read more.
By Vincent H Karam et al, Hôpital Paul Brousse, Villejuif, France. Liver transplantation is associated with consistent improvements in quality of life in the first three years after… read more.
Report from the Joint International Congress of ILTS, ELITA and LICAGE 2014. Recurrence of hepatitis C virus (HCV) infection after transplantation is a major challenge for centres all… read more.
by Professor John O’Grady, Kings College Hospital, London – Liver transplantation is highly successful from the technical perspective, returning the majority of patients to a level of health… read more.